A detailed history of Norwood Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Norwood Financial Corp holds 4,159 shares of MRK stock, worth $418,936. This represents 0.8% of its overall portfolio holdings.

Number of Shares
4,159
Previous 3,959 5.05%
Holding current value
$418,936
Previous $431,000 27.15%
% of portfolio
0.8%
Previous 0.66%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$113.24 - $131.95 $22,648 - $26,389
200 Added 5.05%
4,159 $548,000
Q4 2023

Jan 11, 2024

SELL
$100.18 - $109.02 $20,036 - $21,804
-200 Reduced 4.81%
3,959 $431,000
Q4 2021

Feb 08, 2022

BUY
$72.28 - $90.54 $300,612 - $376,555
4,159 New
4,159 $319,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.